Trial Profile
SPECTRA
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 23 Jul 2013
Price :
$35
*
At a glance
- Drugs Alagebrium chloride (Primary) ; Hydrochlorothiazide
- Indications Isolated systolic hypertension
- Focus Therapeutic Use
- Acronyms SPECTRA
- Sponsors Synvista Therapeutics
- 23 Jul 2013 Treatment table added.
- 14 Nov 2005 New trial record.